| Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma JM Logue, E Zucchetti, CA Bachmeier, GS Krivenko, V Larson, D Ninh, ... Haematologica 106 (4), 978, 2021 | 181 | 2021 |
| High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma EA Dean, RS Mhaskar, H Lu, MS Mousa, GS Krivenko, A Lazaryan, ... Blood Advances 4 (14), 3268-3276, 2020 | 162 | 2020 |
| Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma AJ Sim, MD Jain, NB Figura, JC Chavez, BD Shah, F Khimani, A Lazaryan, ... International Journal of Radiation Oncology* Biology* Physics 105 (5), 1012-1021, 2019 | 127 | 2019 |
| Reasons for migration among medical students from Karachi NA Syed, F Khimani, M Andrades, SK Ali, R Paul Medical education 42 (1), 61-68, 2008 | 122 | 2008 |
| National Marrow Donor Program–sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide BE Shaw, AM Jimenez-Jimenez, LJ Burns, BR Logan, F Khimani, ... Journal of clinical oncology 39 (18), 1971, 2021 | 109 | 2021 |
| Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission M Shadman, M Pasquini, KW Ahn, Y Chen, CJ Turtle, P Hematti, ... Blood, The Journal of the American Society of Hematology 139 (9), 1330-1339, 2022 | 78 | 2022 |
| Tumor microenvironment composition and severe cytokine release syndrome (CRS) influence toxicity in patients with large B-cell lymphoma treated with axicabtagene ciloleucel R Faramand, M Jain, V Staedtke, H Kotani, R Bai, K Reid, SB Lee, ... Clinical Cancer Research 26 (18), 4823-4831, 2020 | 57 | 2020 |
| Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ... JAMA oncology 7 (7), 993-1003, 2021 | 52 | 2021 |
| Antioxidants: their role in health and disease. SA Saeed, MZS Urfy, TM Ali, FW Khimani, AHG Anwar-ul-Hassan Gilani | 47 | 2005 |
| Complementary and alternative medicine: perceptions of medical students from Pakistan K Majeed, H Mahmud, HR Khawaja, S Mansoor, S Masood, F Khimani Medical Education Online 12 (1), 4469, 2007 | 46 | 2007 |
| Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma JM Logue, LC Peres, H Hashmi, CM Colin-Leitzinger, AM Shrewsbury, ... Blood Advances 6 (24), 6109-6119, 2022 | 40 | 2022 |
| IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation BC Betts, J Pidala, J Kim, A Mishra, T Nishihori, L Perez, ... Haematologica 102 (5), 948, 2017 | 40 | 2017 |
| Patterns and predictors of failure in recurrent or refractory large B-cell lymphomas after chimeric antigen receptor T-cell therapy NB Figura, TJ Robinson, AJ Sim, X Wang, B Cao, JC Chavez, BD Shah, ... International Journal of Radiation Oncology* Biology* Physics 111 (5), 1145-1154, 2021 | 36 | 2021 |
| Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma … N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ... Journal of Hematology & Oncology 12, 1-11, 2019 | 33 | 2019 |
| In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation J Pidala, F Beato, J Kim, B Betts, H Jim, E Sagatys, JE Levine, ... Haematologica 103 (3), 531, 2018 | 33 | 2018 |
| A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation N Bejanyan, JA Pidala, X Wang, R Thapa, T Nishihori, H Elmariah, ... Blood Advances 5 (5), 1154-1163, 2021 | 29 | 2021 |
| Increased infections and delayed CD4+ T cell but faster B cell immune reconstitution after post-transplantation cyclophosphamide compared to conventional GVHD prophylaxis in … F Khimani, P Ranspach, H Elmariah, J Kim, J Whiting, T Nishihori, ... Transplantation and Cellular Therapy 27 (11), 940-948, 2021 | 28 | 2021 |
| Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma H Hashmi, AS Mirza, A Darwin, C Logothetis, F Garcia, A Kommalapati, ... Blood Advances 4 (17), 4086-4090, 2020 | 28 | 2020 |
| Allogeneic hematopoietic cell transplantation for Richter syndrome: a single-center experience MA Kharfan-Dabaja, A Kumar, FE Stingo, F Khimani, M Hussaini, E Ayala, ... Clinical Lymphoma Myeloma and Leukemia 18 (1), e35-e39, 2018 | 25 | 2018 |
| Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics M Hamadani, M Ngoya, A Sureda, Q Bashir, CA Litovich, H Finel, Y Chen, ... Blood Advances 6 (3), 920-930, 2022 | 20 | 2022 |
